Volume 9 Supplement 1
Identification of transcription factor and microRNA binding sites in responsible to fetal alcohol syndrome
© Wang et al.; licensee BioMed Central Ltd. 2008
Published: 20 March 2008
This is a first report, using our MotifModeler informatics program, to simultaneously identify transcription factor (TF) and microRNA (miRNA) binding sites from gene expression microarray data. Based on the assumption that gene expression is controlled by combinatorial effects of transcription factors binding in the 5'-upstream regulatory region and miRNAs binding in the 3'-untranslated region (3'-UTR), we developed a model for (1) predicting the most influential cis-acting elements under a given biological condition, and (2) estimating the effects of those elements on gene expression levels. The regulatory regions, TF and miRNA, which mediate the differential genes expression in fetal alcohol syndrome were unknown; microarray data from alcohol exposure paradigm was used. The model predicted strong inhibitory effects of 5' cis-acting elements and stimulatory effects of 3'-UTR under alcohol treatment. Current predictive model derived a key hypothesis for the first time a novel role of miRNAs in gene expression changes associated with abnormal mouse embryo development after alcohol exposure. This suggests that disturbance of miRNA functions may contribute to the alcohol-induced developmental deficiencies.
Understanding global transcriptional and post-transcriptional regulatory mechanisms is a fundamental goal of the post-genomic era . We have previously developed a model-based procedure, MotifModeler, to predict cis-acting elements in the promoter region that affect gene regulation . Here we report a novel extension of this approach to simultaneously identify potential transcription factor and microRNA (miRNA) binding sites from microarray-derived gene expression data and genomic DNA sequences. Conventional computational methods using microarray data to investigate transcriptional regulation focus mainly on identification of transcription factor binding sites [3–5]. However, many cellular processes contribute to changes in eukaryotic gene expression levels, such as the combination of transcriptional events and mRNA degradation (triggered, for example, by miRNAs, or RNA binding proteins). Thus, computational approaches are needed to integrate such cellular processes. In the present study, we describe a novel model-based approach for identifying potential transcription factor and miRNA binding sites from microarray-derived gene expression data and genomic DNA sequences.
MiRNAs bind to complementary sites on the 3'-untranslated regions (3'-UTR) of target mRNAs to induce cleavage and repression of translation [6–8]. In the past decade, several hundred miRNAs have been identified in mammalian cells [9, 10]. Accumulating evidence indicates that miRNAs play critical roles in multiple biological processes, including cell cycle control, cell growth and differentiation, apoptosis, and embryo development [6, 11–15]. At the biochemical level, miRNAs regulate mRNA degradation in a combinatorial manner, i.e., individual miRNA regulates degradation of multiple genes, and regulation of a single gene may be conducted by multiple miRNAs [16, 17]. This combinatorial regulation is thought to be similar in scope to transcription factor partner regulation . Therefore, in addition to transcription factors and other DNA/RNA-binding proteins, comprehensive investigations into transcriptional mechanisms underlying alterations in global gene expression patterns should also consider the emerging role of miRNAs .
We previously developed a model-based procedure, MotifModeler , for identifying cis-acting elements involved in particular biological processes. By testing random subsets of all possible motifs of a fixed size in the 5'-regulatory region and selecting those motifs that best fit a combinatorial model of gene expression levels, MotifModeler identified many known transcription factor binding sites along with novel binding sites. In the current study, we extend the MotifModeler algorithm to include the repressive effects of cis-acting elements in the 3'-untranslated region. The cis-acting elements in the 3'-untranslated region could represent either miRNA binding sites or protein binding sites.
A gene expression profile in an established fetal alcohol syndrome (FAS) biological model system was used to demonstrate the new model. A whole embryo culture system was used to examine the effects of alcohol on embryos without the complications of maternal factors . This in vitro model also provided a difined alcohol concentration in strictly controlled embryonic stage, thus allow for a stringent comparison in high throughput analysis. The gene expression was analysed in parallel to the developmental deficit . The genome-wide gene expression profiles determined on Affymetrix microarrays were analysed to detect potential cis-acting elements which may underlie the effects of alcohol.
Biological model system
To study gene expression changes associated with fetal alcohol exposure, we utilized global gene expression profiles from experiments performed by our group . We have previously defined the timing, concentration, and pattern of alcohol exposure, and we recently characterized gene expression patterns in parallel with developmental abnormalities . In the previous investigation, beginning on gestational day 8.25 (E8.25), 4 C57BL/6 mouse embryos were treated with alcohol (peaking at 88mM) and 4 control without alcohol for 46 hours, and total RNA was isolated for expressional microarray analysis using the Affymetrix Mouse Genome 430 2.0 GeneChip®. In this study, we focused on microarray data that measure the global gene expression profiles in the whole mouse embryos, comparing control embryos (with closed neural tubes) with alcohol treated embryos that had phenotype containing open neural tubes (4-array by 4-array comparison, GEO Accession# GSE9545). After removing genes that were not reliably detected in at least one of the two conditions (control vs. ethanol treated), we selected the 528 probe sets, the expression levels of which were altered significantly (p < 0.05, and fold change > ±1.5). Probe sets not reliably detected  and with absent annotation were removed; for genes with multiple probe sets, we selected the one with the largest fold change to represent the gene. This left 269 genes for analysis, in which 94 were up-regulated and 175 were down-regulated by ethanol.
For the 269 differentially expressed genes, regulatory sequences in both the 5'-proximal flanking region (up to 1,000-bp in length) and the annotated 3'-untranslated region were retrieved from the Build 35 assembly by NCBI (National Center for Biotechnology Information) and downloaded from the UCSC genome browser . Potential transcription factor binding sites and miRNA binding sites were selected from all 6- and 7-bp DNA elements, respectively. After combining reverse complementary sites, there were 2,080 6-bp motif candidates in the 5'-proximal regulatory region. In the 3'-untranslated region, complementary sites were not combined since miRNAs bind to the single-stranded RNA; thus there is a pool of 16,384 7-bp motif candidates.
Modelling gene expression data
g k logarithmic ratio of mRNA expression levels of the k-th gene in the treatment group comparing to control;
t k,i number of transcription factor binding site i in the 5'-regulatory region of the k-th gene;
T k all the transcription factor binding sites having occurrences in the 5'-regulatory region of the k-th gene;
x i functional levels of the i-th transcription factor binding site;
m k,j number of miRNA binding site j in the 3'-UTR of the k-th gene;
M k all the miRNA binding sites having occurrences in the 3'-UTR of the k-th gene;
y j functional levels of the j-th miRNA binding site;
The biological implication of this equation is that the measured gene expression level g k is modeled by a combinatorial effect of transcription, controlled by 5' cis-acting elements, and degradation, regulated by miRNAs and their binding sites in the 3'-untranslated region. Note, however, that the equation can accommodate both positive and negative effects of any site.
where n is total number of genes.
where E is the model error derived in Eq. 5; represents all the combinatorial selections (having n t and n m transcription factor binding sites (TFBS) and miRNA binding sites (MBS), respectively) that include the i-th TFBS or MBS. It has to be noted that the predicted binding sites are indeed cis-acting elements (CAE), which is assumed as TFBS and MBS, respectively. In Eq. 5, α is the power factor that influences the effect of single selections (α > 1). In each iteration, a larger α value usually amplifies the additive contribution of the motif sets with smaller model errors (here, we used α = 5). Similarly, cumulative functional levels of each TFBS and MBS were calculated:
Randomly pick n t and n m elements from pools of TFBS and MBS.
Calculate the predicted model error E (Eq. 4).
Calculate the current contribution score (TCS) of each TFBS and MBS candidate as reciprocal to E, and their and functional levels (X and Y).
Add the current contribution score to the cumulative transcriptional contribution score (TCS) and functional levels (X and Y) (Eq. 6).
Repeat the procedure (1-4) Nrep times. Usually, Nrep will be selected so that each CAE and MBS candidate is evaluated 10,000 times. All the customized programs were written using R 2.4.0 (http://www.r-project.org).
In order to evaluate the significance of the calculated TCS scores, permutation analysis was implemented by randomizing the orders of gene expression data (G in Eq. 2). This permutation not only effectively disconnects the functional relationships of genes and their promoter sequences, but also preserves the promoter contents and the distribution of gene expression.
Correlation of predicted motifs with biologically-known TFBS and miRNA binding sites
We evaluated the sequence similarities of the 5' cis-acting elements (putative TFBS) to 774 distribution matrices of aligned binding sites in the TRANSFAC database using position-specific scoring matrices (PSSM) . For the predicted miRNA binding sites, we compared the selected 7-bp motifs with experimentally-verified miRNAs in the miRNA registry , searching against the complementary sequences of 375 mouse miRNAs.
Selection of TFBS and MBS
Transcriptional contribution scores (TCS) and estimated functional levels (Xm) of top 30 selected TFBS and MBS
5'-proximal regulatory region
Correspondences of predicted binding sites to known binding sites
Correspondence of 27 negative TFBS to the TRANSFAC database
# of matches
Serum response factor
GC box elements
Early growth response gene 3 product
Egr-2/Krox-20 early growth response gene product
Runt-related transcription factor 2 (Runx2)
Stimulating protein 1
Stimulating protein 1
Stimulating protein 1
Stimulating protein 1
Fetal Alz-50 clone 1
Pax-3 binding sites
Hepatic nuclear factor 4
Hepatocyte nuclear factor 4
Imperfect Hogness/Goldberg Box
Rat Olf-1/EBF-associated zinc finger protein
Early B-cell factor
High affinity binding sites for androgen receptor
Winged-helix factor nude
Major T-antigen binding sites
Peroxisome proliferator-activated receptor
Aryl hydrocarbon / dioxin receptor
Neuron-restrictive silencer factor
Correspondences of 3 positive TFBS to the TRANSFAC database
# of matches
Ectopic viral integration site 1 encoded factor
Tumor suppressor p53
Nuclear respiratory factor 1
MiRNAs that match perfectly with predicted 7-bp motifs.
Mature miRNA sequence*
MiRNAs that match with two predicted 7-bp motifs (one G-U pair allowed)
Mature miRNA sequence*
In this study, we extended the application of MotifModeler to simultaneously identify putative cis-acting elements that represent both transcription factor and miRNA binding sites from array-derived gene expression data. Using the microarray data of alcohol-induced gene expression in FAS mouse embryos with distinct biological consequence, our model predicted many TFBS and MBS whose functions differ as a result of alcohol treatment.
Remarkably, in this particular model, it is predicted that most of the 5' motifs showed down-regulatory effects, and all of the 3' miRNA motifs showed up-regulatory effects on gene expression after alcohol treatment. This is clearly shown in Fig. 1B, where most of predicted 6-bp motifs (27 out of top 30) in the 5'-end demonstrated inhibitory effects (Xm < 0) and all the top 30 predicted 7-bp motifs in the 3'-end demonstrated stimulatory effects (Xm > 0). This unbalance observation is unlikely to be random. There was a developmental delay caused by alcohol treatment, as shown by morphological analyses . Therefore, one possible interpretation is that most genes that were at higher levels after alcohol treatment were highly expressed in a previous developmental stage and were not appropriately down-regulated. This could be due to delayed expression of miRNAs that would normally reduce expression.
A number of negative-TFBS are found closely related to the down-regulation of identified gene groups or function of the gene clusters related to developmental deficit in FAS. For example, the Egr-2/Krox-20 early growth response gene product, and early growth response 3 gene product (Egr-2, Egr-3) related to down regulation of Growth GO set related to growth deficit. The Krox, Pax3, and Winged-helix factor nude (Whn) homeodomain are fate-determinants for early development of neural axis and neural patterning. The Neuron-restrictive silencer factor (NRSF), Rat Olf-1/EBF-associated zinc finger protein (Roaz), and Runt-related transcription factor 2 (Osf2, a.k.a. Runx2) are mediating neural specification; these two TF groups together are plausible regulators for down-regulated neurodevelopmental genes seen in embryos with neurodevelopmental deficit [19, 20]. Another outstanding set of predicted TFs, AML, Hogness BOX, and a murine myeloid leukaemia-associated transcription factor (Evi-1) are related to hemopoiesis. They may mediate the global decrease of hemopoiesis genes observed in the microarray data. The group of TFs, nuclear respiratory factor 1 (Nrf-1), tumor suppressor P53 (p53), max, and c-Myc, are predicted which are known to be closely related to mediating apoptosis. The up-regulation of Nrf-1 and P53, and down-regulation of Max-c-Myc may mediate to the downstream gene expression and apoptosis in the alcohol treated embryos. In summary, these predicted TFs / TFBS are closely related to the alteration of core gene expressions related to growth, neural specification, hemopoiesis, and apoptosis which are major developmental deficits in the FAS.
Based on several recent reports that regulatory targets of miRNAs can be identified by searching conserved complementarily motifs in the 3'-UTR, we selected 7-bp motifs as putative miRNA binding sites. Several recent studies suggested that the complementarity of 5'-extremity of miRNA and 3'-UTR of the target gene is critical for the miRNA function [16, 23–25]. Further analysis indicated that starting from whole-genome alignments of five vertebrates, regulatory targets of miRNAs can be identified by searching conserved complementarity, on the 3'-UTR, to the 6-bp seed (nucleotides 2-7) of miRNA. An additional requirement of either conserved matches at nucleotide 8 of miRNA or conserved adenosines at position 1 of target mRNA greatly increases signal-to-noise ratios of the prediction, and therefore is desired to anchor the miRNA binding .
MiRNA target prediction is a challenging and unsettled area. Most bioinformatic procedures to predict miRNA targets take advantage of cross-species comparison, based on the assumption that target sites of miRNAs are evolutionarily conserved [10, 26, 27]. A more recent study demonstrated that putative miRNA binding sites that are not conserved across evolution also mediate repression . This observation not only allows but also requires us to identify potential miRNA binding sites from genomic sequences of single organism, as implemented here. Other approaches have predicted post-transcriptional mechanisms using sequence information within one species [29, 30]. Our method, however, is the first attempt to integrate the effects of TFBS and MBS into array-derived gene expression data analysis in a mammalian system.
As many RNA-binding proteins bind in the 3'-UTR, it is important to acknowledge that post-transcriptional regulation of gene expression is a multi-factorial phenomenon that includes miRNA and other molecules. In addition to facilitating translation, other factors can destabilize mRNA and thus serve similar functions as the RNA Induced Silencing Complex (RISC) recruited by miRNA . An example of such an RNA-binding protein includes AU-rich elements (ARE) , a family of PUF proteins . Our method identifies cis-acting elements in the 3'-untranslated region that could represent either miRNA binding sites or protein binding sites. This application in the field of fetal alcohol syndrome is in its infancy. Experimental evaluation is necessary to better understand the transcriptional and post-transcriptional mechanisms that regulate the global gene expression pattern.
We thank Ronald E. Jerome and Chunxiao Zhu for expert assistance with the microarray studies, which were carried out using the facilities of the Center for Medical Genomics at Indiana University School of Medicine. The authors also thank Dr. Changyu Shen for valuable discussion and suggestions. This work is supported by NIH P50 AA07611, AA016698 (FCZ), China National 863 High-Tech Program 2007AA02Z302 (YL), and the Indiana Genomics Initiative of Indiana University (supported in part by the Lilly Endowment, Inc., YL).
This article has been published as part of BMC Genomics Volume 9 Supplement 1, 2008: The 2007 International Conference on Bioinformatics & Computational Biology (BIOCOMP'07). The full contents of the supplement are available online at http://www.biomedcentral.com/1471-2164/9?issue=S1.
- Collins FS, Green ED, Guttmacher AE, Guyer MS: A vision for the future of genomics research. Nature. 422: 835-47. 10.1038/nature01626. Apr 24 2003
- Liu Y, Taylor MW, Edenberg HJ: Model-based identification of cis-acting elements from microarray data. Genomics. 88: 452-61. 10.1016/j.ygeno.2006.04.006. Oct 2006
- Bussemaker HJ, Li H, Siggia ED: Regulatory element detection using correlation with expression. Nat Genet. 27: 167-71. 10.1038/84792. Feb 2001
- Liu XS, Brutlag DL, Liu JS: An algorithm for finding protein-DNA binding sites with applications to chromatin-immunoprecipitation microarray experiments. Nat Biotechnol. 20: 835-9. Aug 2002
- Yap YL, Lam DC, Luc G, Zhang XW, Hernandez D, Gras R, Wang E, Chiu SW, Chung LP, Lam WK, Smith DK, Minna JD, Danchin A, Wong MP: Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays. Nucleic Acids Res. 2005, 33: 409-21. 10.1093/nar/gki188.PubMedPubMed CentralView ArticleGoogle Scholar
- Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116: 281-97. 10.1016/S0092-8674(04)00045-5. Jan 23 2004
- Lee R, Feinbaum R, Ambros V: A short history of a short RNA. Cell. 116: S89-92. 10.1016/S0092-8674(04)00035-2. 1 p following S96, Jan 23 2004
- Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 75: 843-54. 10.1016/0092-8674(93)90529-Y. Dec 3 1993
- Griffiths-Jones S: The microRNA Registry. Nucleic Acids Res. 32: D109-11. 10.1093/nar/gkh023. Jan 1 2004
- Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K, Lander ES, Kellis M: Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature. 434: 338-45. 10.1038/nature03441. Mar 17 2005
- Ambros V: microRNAs: tiny regulators with great potential. Cell. 107: 823-6. 10.1016/S0092-8674(01)00616-X. Dec 28 2001
- Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM: bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell. 113: 25-36. 10.1016/S0092-8674(03)00231-9. Apr 4 2003
- Cheng AM, Byrom MW, Shelton J, Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005, 33: 1290-7. 10.1093/nar/gki200.PubMedPubMed CentralView ArticleGoogle Scholar
- Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS: A microRNA array reveals extensive regulation of microRNAs during brain development. Rna. 9: 1274-81. 10.1261/rna.5980303. Oct 2003
- Wienholds E, Kloosterman WP, Miska E, Alvarez-Saavedra E, Berezikov E, de Bruijn E, Horvitz HR, Kauppinen S, Plasterk RH: MicroRNA expression in zebrafish embryonic development. Science. 309: 310-1. 10.1126/science.1114519. Jul 8 2005
- Brennecke J, Stark A, Russell RB, Cohen SM: Principles of microRNA-target recognition. PLoS Biol. 3: e85-10.1371/journal.pbio.0030085. Mar 2005
- Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N: Combinatorial microRNA target predictions. Nat Genet. 37: 495-500. 10.1038/ng1536. May 2005
- Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120: 15-20. 10.1016/j.cell.2004.12.035. Jan 14 2005
- Ogawa T, Kuwagata M, Ruiz J, Zhou FC: Differential teratogenic effect of alcohol on embryonic development between C57BL/6 and DBA/2 mice: a new view. Alcohol Clin Exp Res. 29: 855-63. 10.1097/01.ALC.0000163495.71181.10. May 2005
- Zhou FC, Zhao Q, Kuwagata M, Liu Y, Goodlette CR, Liang T, McClintick JN, Edenberg HJ, Li L: Fetal alcohol exposure reduces embryonic development and expression of growth and neurotrophic genes. in preparation
- McClintick JN, Edenberg HJ: Effects of filtering by Present call on analysis of microarray experiments. BMC Bioinformatics. 2006, 7: 49-10.1186/1471-2105-7-49.PubMedPubMed CentralView ArticleGoogle Scholar
- Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu YT, Roskin KM, Schwartz M, Sugnet CW, Thomas DJ, Weber RJ, Haussler D, Kent WJ: The UCSC Genome Browser Database. Nucleic Acids Res. 31: 51-4. 10.1093/nar/gkg129. Jan 1 2003
- Lai EC: Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet. 30: 363-4. 10.1038/ng865. Apr 2002
- Stark A, Brennecke J, Russell RB, Cohen SM: Identification of Drosophila MicroRNA targets. PLoS Biol. 1: E60-10.1371/journal.pbio.0000060. Dec 2003
- Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB: Prediction of mammalian microRNA targets. Cell. 115: 787-98. 10.1016/S0092-8674(03)01018-3. Dec 26 2003
- Chan CS, Elemento O, Tavazoie S: Revealing Posttranscriptional Regulatory Elements Through Network-Level Conservation. PLoS Comput Biol. 1: e69-10.1371/journal.pcbi.0010069. Dec 9 2005
- Grun D, Wang YL, Langenberger D, Gunsalus KC, Rajewsky N: microRNA target predictions across seven Drosophila species and comparison to mammalian targets. PLoS Comput Biol. 1: e13-10.1371/journal.pcbi.0010013. Jun 2005
- Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB, Bartel DP: The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science. 310: 1817-21. 10.1126/science.1121158. Dec 16 2005
- Sood P, Krek A, Zavolan M, Macino G, Rajewsky N: Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci U S A. 103: 2746-51. 10.1073/pnas.0511045103. Feb 21 2006
- Foat BC, Houshmandi SS, Olivas WM, Bussemaker HJ: Profiling condition-specific, genome-wide regulation of mRNA stability in yeast. Proc Natl Acad Sci U S A. 102: 17675-80. 10.1073/pnas.0503803102. Dec 6 2005
- Zhang W, Wagner BJ, Ehrenman K, Schaefer AW, DeMaria CT, Crater D, DeHaven K, Long L, Brewer G: Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol Cell Biol. 13: 7652-65. Dec 1993
- Zubiaga AM, Belasco JG, Greenberg ME: The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol. 15: 2219-30. Apr 1995
- Murata Y, Wharton RP: Binding of pumilio to maternal hunchback mRNA is required for posterior patterning in Drosophila embryos. Cell. 80: 747-56. 10.1016/0092-8674(95)90353-4. Mar 10 1995
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.